國家衛生研究院 NHRI:Item 3990099045/12038
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 907807      在线人数 : 931
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/12038


    题名: Hemodynamics-based strategy of using retinoic acid receptor and retinoid X receptor agonists to induce microRNA-10a and inhibit atherosclerotic lesion
    作者: Lee, DY;Chiu, JJ
    贡献者: Institute of Cellular and Systems Medicine
    摘要: The protocols in this chapter describe methods for identifying the functional roles of retinoic acid receptor (RAR) and retinoid X receptor (RXR) signaling in atherosclerosis and developing RARalpha/RXRalpha-specific agonists as hemodynamics-based therapeutic components for atherosclerosis treatment. In vitro cell culture flow system is used to elucidate the effects of different flow patterns and shear stresses, i.e., atherogenic oscillatory shear stress (OS) vs. atheroprotective pulsatile shear stress (PS), on RAR/RXR signaling and inflammatory responses in vascular endothelial cells (ECs). Western blotting, nuclear and cytoplasmic protein extraction, immunoprecipitation, and in situ proximity ligation assay are used to examine the expression, location, and association of RARs (i.e., RARalpha, RARbeta, and RARgamma) and RXRs (i.e., RXRalpha, RXRbeta, and RXRgamma) in ECs in response to OS vs. PS. Chromatin immunoprecipitation is used to examine the binding activity of RARalpha/RA-responsive elements (RARE). RT-microRNA (miR) quantitative real-time PCR and RT-PCR are used to detect the expressions of miR-10a and pro-inflammatory molecules, respectively. Specific siRNAs of RARalpha and RXRalpha, precursor miR-10a (PreR-10a), and antagomiR-10a (AMR-10a) are used to elucidate the regulatory roles of RARalpha, RXRalpha, and miR-10a in pro-inflammatory signaling in ECs. RARalpha/RXRalpha-specific agonists are used to induce miR-10a expression and inhibit OS-induced pro-inflammatory signaling in ECs in vitro. Apolipoprotein E-deficient (ApoE(-/-)) mice are used as an atherosclerotic animal model. Administration of ApoE(-/-) mice with RARalpha/RXRalpha-specific agonists results in inhibitions in atherosclerotic lesion formation. Co-administration of ApoE(-/-) mice with RARalpha/RXRalpha agonists and AMR-10a is performed to identify the role of miR-10a in RARalpha/RXRalpha agonists-mediated inhibition in atherosclerotic lesions. Oil Red O staining and H&E staining are used to examine the levels of atherosclerotic lesions in the vessel wall. In situ miR hybridization and immunohistochemical staining are used to detect the expression of miR-10a and pro-inflammatory molecules and the infiltration of inflammatory cells in the vessel wall. RARalpha/RXRalpha-specific agonists are used to mimic the atheroprotective effects of PS to induce endothelial miR-10a and hence repress OS-induced pro-inflammatory signaling and atherosclerotic lesion formation in vivo. The results indicate that RAR/RXR-specific agonists have great potential to be developed as hemodynamics-based therapeutic components for atherosclerosis treatment.
    日期: 2019-07-30
    關聯: Methods in Molecular Biology. 2019 Jul 30;2019:143-169.
    Link to: http://dx.doi.org/10.1007/978-1-4939-9585-1_11
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85070539113
    显示于类别:[裘正健] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    PUB31359395.pdf675KbAdobe PDF256检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈